CVE-2023-6078

Name: CVE-2023-6078
Creator: NVD / NIST
Published: 2024-02-01T14:15:55.81+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

CRITICALCVSS 9.8/10EPSS 1.64%

Last modified Jun 17, 2026

CVE-2023-6078 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.. EPSS estimates a 1.64% chance of exploitation in the next 30 days.

Description

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

Metrics

CVSS 3.1

9.8/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

1.64%

73.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
3ds	Biovia Materials Studio	>= 2021, <= 2023

References

https://www.3ds.com/vulnerability/advisoriesVendor Advisory
https://www.3ds.com/vulnerability/advisoriesVendor Advisory

Timeline

Published: Feb 1, 2024
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-6078?

How severe is CVE-2023-6078?

CVE-2023-6078 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 1.64% probability of exploitation in the next 30 days.

How do I fix CVE-2023-6078?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-6078?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST